Market Tracker

10/31 4:33pm ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.81
Data as of 4:02pm ET
 +0.0101 / +1.26%
Today’s Change
0.69
Today|||52-Week Range
1.80
-34.15%
Year-to-Date

Today’s Trading

Previous close0.80
Today’s open0.80
Day’s range0.78 - 0.82
Volume244,496
Average volume (3 months)314,041
Market cap$40.6M
Dividend yield--
Data as of 4:02pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-75.00%
Earnings growth (this year)+27.78%
Earnings growth (next 5 years)--
Revenue growth (last year)-49.95%
P/E ratioNM
Price/Sales13.51
Price/Book4.19

Competitors

 Today’s
change
Today’s
% change
ENZNEnzon Pharmaceutical...-0.05-5.40%
HTBXHeat Biologics Inc+0.11+1.72%
CEMIChembio Diagnostics ...-0.06-1.38%
ANTHAnthera Pharmaceutic...-0.05-2.63%
Data as of 3:59pm ET, 10/31/2014

Financials

Last reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$3.5M
Annual profit (last year)-$16.0M
Net profit margin-461.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Ramin Najafi
CFO, CAO, Secretary &
Treasurer
Thomas J. Paulson
Corporate headquarters
Emeryville, California

Forecasts